Cecilia Pui Chi CHIU - South San Francisco CA, US Daniel K. KIRCHHOFER - South San Francisco CA, US Andrew PETERSON - South San Francisco CA, US Ganesh A. KOLUMAM - South San Francisco CA, US Monica Kong BELTRAN - South San Francisco CA, US Paul MORAN - South San Francisco CA, US Wei LI - South San Francisco CA, US Xanthe LAM - South San Francisco CA, US Lin LUIS - South San Francisco CA, US Ada HUI - South San Francisco CA, US Whittemore TINGLEY - South San Francisco CA, US John Douglas DAVIS - South San Francisco CA, US Nageshwar R. BUDHA - South San Francisco CA, US
YAN WU - SAN FRANCISCO CA, US CECILIA CHIU - SAN CARLOS CA, US DANIEL KIRCHHOFER - LOS ALTOS CA, US ANDREW PETERSON - SAN FRANCISCO CA, US GANESH KOLUMAM - FOSTER CITY CA, US MONICA KONG BELTRAN - Foster City CA, US PAUL MORAN - Oakland CA, US WEI LI - PALO ALTO CA, US
- South San Francisco CA, US Cecilia Pui Chi Chiu - South San Francisco CA, US Daniel K. Kirchhofer - South San Francisco CA, US Andrew Peterson - South San Francisco CA, US Ganesh A. Kolumam - South San Francisco CA, US Monica Kong Beltran - South San Francisco CA, US Paul Moran - South San Francisco CA, US Wei Li - South San Francisco CA, US Xanthe Lam - South San Francisco CA, US Lin Luis - South San Francisco CA, US Ada Hui - South San Francisco CA, US Whittemore Tingley - South San Francisco CA, US John Douglas Davis - South San Francisco CA, US Nageshwar R. Budha - South San Francisco CA, US
International Classification:
C07K 16/40
Abstract:
The invention provides anti-PCSK9 antibodies, formulations, dosing regimens, and methods of using the same.